Skip to content
lifestyle.sli.mg
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
IN8bio, Inc
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
September 9, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 10, 2026
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 6, 2026
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
June 3, 2026
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
June 1, 2026
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 21, 2026
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
May 6, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 3, 2026
1
2
Next Page
→